Caplin Point Laboratories Profit & Loss Annual

BSE: 524742 | NSE: CAPLIPOINT | ISIN: INE475E01026 | Sector: Biotechnology & Drugs
2,195.00 -89.65 (-3.92%)Updated : 23 May 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Revenue 1,937.471,694.101,466.731,269.41
Total Revenue 1,937.471,694.101,466.731,269.41
Costof Revenue Total 770.84762.91694.80581.85
Gross Profit 1,166.63931.19771.93687.56
Selling/ General/ Admin Expenses Total 177.72305.11266.98233.31
Depreciation/ Amortization 65.9653.4444.9946.90
Other Operating Expenses Total 341.98---
Total Operating Expense 1,356.501,195.181,069.96921.33
Operating Income 580.97498.92396.77348.08
Interest Inc( Exp) Net- Non- Op Total -0.6260.9849.8234.54
Other Net 96.435.185.123.08
Net Income Before Taxes 676.78564.43451.35385.82
Provisionfor Income Taxes 135.69103.0174.3677.37
Net Income After Taxes 541.09461.42376.99308.45
Minority Interest -4.78-4.33-0.73-8.61
Net Income Before Extra Items 536.31457.09376.26299.84
Net Income 536.31457.09376.26299.84
Income Availableto Com Excl Extra Ord 536.31457.09376.26299.84
Income Availableto Com Incl Extra Ord 536.31457.09376.26299.84
Diluted Net Income 536.31457.09376.26299.84
Diluted Weighted Average Shares 7.637.637.657.64
Diluted EPS Excluding Extra Ord Items 70.2559.9049.1839.26
Diluted Normalized EPS 70.2559.9749.2239.25
period Length 12.0012.0012.0012.00
period Type ----
Research Development -73.7263.1959.27
Gain( Loss)on Saleof Assets --0.65-0.360.12
DPS- Common Stock Primary Issue -5.004.504.00
Unusual Expense( Income) ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
436.30+10.20(2.39%)
2,413.50+50.65(2.14%)